view original post

Pluristem Therapeutics Inc. (NASDAQ:PSTI) has a beta value of 2.12 and has seen 29.66 million shares traded in the recent trading session. The company, currently valued at $45.60M, closed the recent trade at $1.78 per share which meant it gained $0.31 on the day or 21.08% during that session. The PSTI stock price is -455.62% off its 52-week high price of $9.89 and 23.6% above the 52-week low of $1.36. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.35 million shares traded. The 3-month trading volume is 224.40K shares.

The consensus among analysts is that Pluristem Therapeutics Inc. (PSTI) is an Overweight stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 3 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.38.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Sporting 21.08% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, 01/07/22 when the PSTI stock price touched $1.78 or saw a rise of 2.2%. Year-to-date, Pluristem Therapeutics Inc. shares have moved 0.68%, while the 5-day performance has seen it change 0.68%. Over the past 30 days, the shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) have changed -38.75%. Short interest in the company has seen 0.34 million shares shorted with days to cover at 1.94.

Wall Street analysts have a consensus price target for the stock at $7.17, which means that the shares’ value could jump 75.17% from the levels at last check today. The projected low price target is $3.00 while the price target rests at a high of $9.50. In that case, then, we find that the latest price level in today’s session is -433.71% off the targeted high while a plunge would see the stock gain -68.54% from the levels at last check today.

Pluristem Therapeutics Inc. (PSTI) estimates and forecasts

Figures show that Pluristem Therapeutics Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -59.95% over the past 6 months, with this year growth rate of -5.08%, compared to 7.80% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2022 fiscal year revenue. Growth estimates for the current quarter are 22.40% and 16.70% for the next quarter.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 9.50% over the past 5 years.

PSTI Dividends

Pluristem Therapeutics Inc. is expected to release its next earnings report between February 15 and February 18 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Pluristem Therapeutics Inc. (NASDAQ:PSTI)’s Major holders

Insiders own 12.02% of the company shares, while shares held by institutions stand at 14.14% with a share float percentage of 16.08%. Investors are also buoyed by the number of investors in a company, with Pluristem Therapeutics Inc. having a total of 60 institutions that hold shares in the company. The top two institutional holders are ARK Investment Management, LLC with over 0.93 million shares worth more than $2.45 million. As of Sep 29, 2021, ARK Investment Management, LLC held 2.88% of shares outstanding.

The other major institutional holder is Nia Impact Advisors, LLC, with the holding of over 0.73 million shares as of Sep 29, 2021. The firm’s total holdings are worth over $1.94 million and represent 2.28% of shares outstanding.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also the top two Mutual Funds that are holding company’s shares are ARK ETF Tr-ARK Israel Innovative Technology ETF and Shelton Funds-Green Alpha Fund. As of Oct 30, 2021, the former fund manager holds about 3.79% shares in the company for having 1.22 million shares of worth $3.23 million while later fund manager owns 0.24 million shares of worth $0.72 million as of Aug 30, 2021, which makes it owner of about 0.75% of company’s outstanding stock.